Evidence map›Paper›PMID 17495034›Full record

ArticleThe Journal of physiology2007

Neurally released pituitary adenylate cyclase-activating polypeptide enhances guinea pig intrinsic cardiac neurone excitability.

John D Tompkins, Jeffrey L Ardell, Donald B Hoover, Rodney L Parsons

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.3field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. What's New in Endocrinology: The Chromaffin Cell.Frontiers in endocrinology · 2018
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Angiotensin II potentiates adrenergic and muscarinic modulation of guinea pig intracardiac neurons.American journal of physiology. Regulatory, integrative and comparative physiology · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

John D TompkinsDepartment of Anatomy and Neurobiology, College of Medicine, University of Vermont, Burlington, VT 05405, USA.
Jeffrey L Ardell
Donald B Hoover
Rodney L Parsons
East Tennessee State University · USUniversity of Vermont · US

Funding

Proteomics Core for Neuroscience P20 RR16435P20RR016435 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI MARTIN-CARABALLO, MIGUEL · 2001 to 2010
$23.5M
Myocardial Ischemia Remodels the Cardiac Nervous SystemR01HL071830 · NHLBI · EAST TENNESSEE STATE UNIVERSITY · PI ARDELL, JEFFREY L · 2005 to 2013
$2.8M
Modulation of parasympathetic neurons by PACAP peptidesR01HL065481 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI PARSONS, RODNEY L · 2002 to 2005
$1.2M
Role of Nonclassical Transmitters in Cardiac GangliaR01HL054633 · NHLBI · EAST TENNESSEE STATE UNIVERSITY · PI HOOVER, DONALD B · 1997 to 2004
$860k
NCRR NIH HHS P20 RR016435NCRR NIH HHS P20 RR-16435NHLBI NIH HHS HL-54633NHLBI NIH HHS HL-65481NHLBI NIH HHS HL-71830NHLBI NIH HHS R01 HL054633NHLBI NIH HHS R01 HL065481NHLBI NIH HHS R01 HL071830
6 · The paper itself

Abstract

Intracellular recordings were made in vitro from guinea-pig cardiac ganglia to determine whether endogenous neuropeptides such as pituitary adenylate cyclase-activating polypeptide (PACAP) or substance P released during tetanic neural stimulation modulate cardiac neurone excitability and/or contribute to slow excitatory postsynaptic potentials (sEPSPs). When nicotinic and muscarinic receptors were blocked by hexamethonium and atropine, 20 Hz stimulation for 10 s initiated a sEPSP in all innervated neurones. In 40% of the cells, excitability was enhanced after termination of the sEPSP. This suggested that non-cholinergic receptor-mediated mechanisms contributed to the sEPSP and modulated neuronal excitability. Exogenous PACAP and substance P initiated a slow depolarization in the neurones whereas neuronal excitability was only increased by PACAP. When ganglia were treated with the PAC1 antagonist PACAP6-38 (500 nM), the sEPSP evoked by 20 Hz stimulation was reduced by approximately 50% and an enhanced excitability occurred in only 10% of the cells. These observations suggested that PACAP released from preganglionic nerve terminals during tetanic stimulation enhanced neuronal excitability and evoked sEPSPs. After addition of 1 nM PACAP to the bath, 7 of 9 neurones exhibited a tonic firing pattern whereas in untreated preparations, the neurons had a phasic firing pattern. PACAP6-38 (500 nM) diminished the increase in excitability caused by 1 nM PACAP so that only 4 of 13 neurones exhibited a tonic firing pattern and the other 9 cells retained a phasic firing pattern. These findings indicate that PACAP can be released by tetanic neural stimulation in vitro and increase the excitability of intrinsic cardiac neurones. We hypothesize that in vivo PACAP released during preganglionic firing may modulate neurotransmission within the intrinsic cardiac ganglia.

Indexed as

Synaptic TransmissionAnimalsAtropineAutonomic Fibers, PreganglionicElectric StimulationExcitatory Postsynaptic PotentialsGanglia, ParasympatheticGuinea PigsHeartHeart AtriaHexamethoniumIn Vitro TechniquesKineticsMuscarinic AntagonistsNeuronsNicotinic AntagonistsAtropineHexamethoniumMuscarinic AntagonistsNicotinic AntagonistsPeptide Fragmentspituitary adenylate-cyclase-activating-peptide (6-38)Pituitary Adenylate Cyclase-Activating PolypeptideReceptors, MuscarinicReceptors, NicotinicReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type ISubstance P

Identifiers

PMID17495034
PMCPMC2075297
OpenAlexW1605754644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.